HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zogenix Inc.

www.zogenix.com

Latest From Zogenix Inc.

Finance Watch: Biotech Stocks Down, But Holding Up Better Than Broader Indices

Public Company Edition: Benefitting from hope that biopharma interventions will help the coronavirus pandemic, the industry is faring better than others in the stock market, including the ability to launch IPOs. Also, BridgeBio leads recent financings and PDL is on track to dissolve by year-end.

Financing Business Strategies

Zogenix’s Fintepla Reduces Drop Seizure Rates, But Is It Enough?

Despite positive Phase III results in Lennox-Gastaut syndrome, the effect of the company’s low-dose fenfluramine on serious seizures may not be as good as seen with GW Pharma’s Epidiolex. 

Clinical Trials Comparative Effectiveness

Neurocrine Adds Epilepsy Assets From Xenon

Neurocrine plans to advance XEN901 into Phase II in a rare pediatric epilepsy indication while eyeing opportunity in adult focal epilepsy. Xenon increases its runway to develop a pair of mid-stage epilepsy drugs.

Business Strategies Deals

Deal Watch: GSK Furthers Cancer Gene Therapy Plans Via Lyell Collaboration

GSK hopes the San Francisco biotech’s technology can help its cell therapy pipeline address solid tumors. Avacta partners with ADC on antibody-drug conjugates.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • SJ2 Therapeutics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Zogenix Inc.
  • Senior Management
  • Stephen J Farr, PhD, Pres. & CEO
    Michael P Smith, EVP, CFO, Treasurer & Secretary
    Bradley S Galer, MD, EVP, CMO
    Gail M Farfel, PhD, EVP, Chief Dev. Officer
    Ashish Sagrolikar, EVP, Chief Commercial Officer
  • Contact Info
  • Zogenix Inc.
    Phone: (858) 259-1165
    5858 Horton St.
    Ste. 455
    Emeryville, CA 94608
    USA
UsernamePublicRestriction

Register